Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India

View ORCID ProfileEpke A Le Rutte, View ORCID ProfileLuc E Coffeng, Johanna Muñoz, View ORCID ProfileSake J de Vlas
doi: https://doi.org/10.1101/2020.10.26.20219758
Epke A Le Rutte
aDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
bDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
cUniversity of Basel, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Epke A Le Rutte
  • For correspondence: epke.lerutte{at}swisstph.ch
Luc E Coffeng
aDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luc E Coffeng
Johanna Muñoz
aDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sake J de Vlas
aDepartment of Public Health, Erasmus MC, University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sake J de Vlas
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: October 2020 to July 2025

AbstractFullPdf
Oct 20202841037
Nov 2020104419
Dec 202040612
Jan 202162714
Feb 202163213
Mar 2021751011
Apr 20216746
May 20214615
Jun 20216147
Jul 202134410
Aug 202132717
Sep 202137518
Oct 202128018
Nov 202133123
Dec 20212002
Jan 202213611
Feb 20221913
Mar 20222026
Apr 20222503
May 202224014
Jun 20221414
Jul 20221601
Aug 20222535
Sep 202222011
Oct 20227317
Nov 20222015
Dec 20221436
Jan 202313103
Feb 20231476
Mar 2023602
Apr 20231712
May 20231129
Jun 2023844
Jul 2023702
Aug 202315115
Sep 20231254
Oct 2023821
Nov 20231151
Dec 20231124
Jan 2024914
Feb 202412214
Mar 2024626
Apr 20241276
May 2024301
Jun 20241444
Jul 2024914
Aug 202416913
Sep 20242333
Oct 2024965
Nov 2024927
Dec 2024523
Jan 2025412
Feb 2025460
Mar 202528165
Apr 20251427
May 20251244
Jun 2025221010
Jul 202518814
Back to top
PreviousNext
Posted October 27, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India
Epke A Le Rutte, Luc E Coffeng, Johanna Muñoz, Sake J de Vlas
medRxiv 2020.10.26.20219758; doi: https://doi.org/10.1101/2020.10.26.20219758
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India
Epke A Le Rutte, Luc E Coffeng, Johanna Muñoz, Sake J de Vlas
medRxiv 2020.10.26.20219758; doi: https://doi.org/10.1101/2020.10.26.20219758

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)